fda green list import alert 66-80 glp-1 apis semaglutide tirzepatide creates "green list" to block unsafe imports FDA's green list cracks down – September 8, 2025: FDA launches

A healthcare provider may recommend slowly tapering off Ozempic before starting the new medication to minimize side effects

Consumer Products : From specialized meal replacement products to appetite-adjusting snacks, consumer-facing products designed for the GLP-1 user present significant market potential

If your main goal is weight loss, Ipamorelin is generally the better option because it creates a stronger and more targeted release of growth hormone that helps burn body fat and preserves lean body mass

Even a 15-minute daily walk makes a measurable difference in overall GLP-1 outcomes beyond just constipation relief

Inhibition of CPT1a as a Prognostic Marker Can Synergistically Enhance the Antileukemic Activity of ABT199